939767 - Exelixis, Inc. - SEC Form 4 Insider Trading Screener

Services - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research - EXEL (939767)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S30-0-1+0+99

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-11-15
EXELLamb PeterEVP, Scientific Strategy, CSOF - Tax$24.75-2,204142,799-2%-$54,549
2017-11-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOF - Tax$24.75-2,609269,582-1%-$64,573
2017-11-15
EXELHaley Patrick J.SVP, CommercialF - Tax$24.75-3,739123,668-3%-$92,540
2017-11-15
EXELHessekiel JeffreyEVP, GCF - Tax$24.75-2,120317,256-1%-$52,470
2017-11-15
EXELSenner Christopher J.EVP, CFOF - Tax$24.75-2,762164,536-2%-$68,360
2017-11-15
EXELMorrissey MichaelPres, CEOF - Tax$24.75-8,347321,371-3%-$206,588
D
2017-10-03
EXELHaley Patrick J.SVP, CommercialA - Grant$0.00+50,000127,407+65%+$0
D
2017-10-03
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOA - Grant$0.00+75,000272,191+38%+$0
D
2017-10-03
EXELLamb PeterEVP, Scientific Strategy, CSOA - Grant$0.00+55,000145,003+61%+$0
D
2017-10-03
EXELHessekiel JeffreyEVP, GCA - Grant$0.00+50,000318,260+19%+$0
D
2017-10-03
EXELSenner Christopher J.EVP, CFOA - Grant$0.00+62,500167,298+60%+$0
D
2017-10-03
EXELMorrissey MichaelPres, CEOA - Grant$0.00+80,000329,718+32%+$0
DM
2017-09-27
EXELHessekiel JeffreyEVP, GCM - OptEx$1.90+27,302268,260+11%+$51,874
DM
2017-09-27
EXELHessekiel JeffreyEVP, GCS - Sale+OE$24.28-27,302268,260-9%-$663,018
DM
2017-09-26
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$9.91+100,000197,191+103%+$991,000
DM
2017-09-26
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.79-100,000197,191-34%-$2,378,667
2017-09-22
EXELPapadopoulos SteliosDirS - Sale$25.40-10,0001,034,314-1%-$254,000
M
2017-09-18
EXELPapadopoulos SteliosDirS - Sale$27.68-200,0001,044,314-16%-$5,535,387
2017-09-14
EXELHaley Patrick J.SVP, CommercialS - Sale$27.21-60,64075,046-45%-$1,650,014
M
2017-09-12
EXELWillsey LanceDirS - Sale$26.88-100,000468,273-18%-$2,688,000
D
2017-09-12
EXELSenner Christopher J.EVP, CFOM - OptEx$3.66+100,000104,798>999%+$366,000
D
2017-09-12
EXELSenner Christopher J.EVP, CFOS - Sale+OE$26.79-100,000104,798-49%-$2,679,000
DM
2017-09-12
EXELMorrissey MichaelPres, CEOM - OptEx$1.70+300,000249,718-597%+$510,000
DM
2017-09-12
EXELMorrissey MichaelPres, CEOS - Sale+OE$26.90-300,000249,718-55%-$8,071,000
2017-05-30
EXELHaley Patrick J.SVP, CommercialS - Sale$18.46-5,000135,686-4%-$92,300
AD
2017-05-25
EXELPapadopoulos SteliosDirA - Grant$0.00+5,8431,244,3140%+$0
D
2017-05-25
EXELPoste GeorgeDirA - Grant$0.00+5,84383,398+8%+$0
D
2017-05-25
EXELWyszomierski Jack LDirA - Grant$0.00+5,84378,803+8%+$0
D
2017-05-25
EXELPapadopoulos SteliosDirA - Grant$0.00+5,8431,234,3140%+$0
D
2017-05-25
EXELMarchesi Vincent TDirA - Grant$0.00+5,843125,913+5%+$0
D
2017-05-15
EXELFeldbaum Carl BDirM - OptEx$8.75+19,00034,733+121%+$166,190
D
2017-05-15
EXELFeldbaum Carl BDirS - Sale+OE$21.58-32,98834,733-49%-$711,831
D
2017-05-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$5.04+12,501197,191+7%+$63,005
DM
2017-05-08
EXELMorrissey MichaelPres, CEOM - OptEx$1.88+211,300249,716+550%+$397,380-2
DM
2017-05-08
EXELMorrissey MichaelPres, CEOS - Sale+OE$21.87-211,300249,716-46%-$4,622,159-2
DM
2017-05-03
EXELMorrissey MichaelPres, CEOM - OptEx$1.90+259,149249,668-2733%+$492,383-10
DM
2017-05-03
EXELMorrissey MichaelPres, CEOS - Sale+OE$22.24-259,149249,668-51%-$5,762,838-10
D
2017-05-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$9.91+89,910184,690+95%+$891,008-2-3
D
2017-05-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.01-89,910184,690-33%-$2,068,519-2-3
D
2017-04-17
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$9.91+10,090182,329+6%+$99,992+1+2
D
2017-04-03
EXELMarchesi Vincent TDirM - OptEx$10.53+10,000120,070+9%+$105,300-4-5+6
D
2017-04-03
EXELMarchesi Vincent TDirS - Sale+OE$21.30-10,000120,070-8%-$213,000-4-5+6
D
2017-03-31
EXELWyszomierski Jack LDirM - OptEx$10.53+10,00072,960+16%+$105,300-2-6+7
D
2017-03-31
EXELWyszomierski Jack LDirS - Sale+OE$21.57-5,15072,960-7%-$111,086-2-6+7
D
2017-03-27
EXELCohen CharlesDirM - OptEx$10.53+10,000248,180+4%+$105,300-10+3
2017-03-27
EXELHessekiel JeffreyEVP, GCS - Sale$21.02-6,884267,946-3%-$144,702-10+3
D
2017-03-16
EXELHessekiel JeffreyEVP, GCG - Gift$0.00-3,000274,830-1%-$0+2+1+2
D
2017-03-22
EXELHessekiel JeffreyEVP, GCM - OptEx$1.70+55,000274,830+25%+$93,500+2+1+2
D
2017-03-22
EXELHessekiel JeffreyEVP, GCS - Sale+OE$20.54-23,787274,830-8%-$488,585+2+1+2
D
2017-03-20
EXELFeldbaum Carl BDirM - OptEx$10.53+10,00048,721+26%+$105,3000+4+3
D
2017-03-20
EXELFeldbaum Carl BDirS - Sale+OE$21.77-10,00048,721-17%-$217,7000+4+3
D
2017-03-20
EXELPapadopoulos SteliosDirM - OptEx$10.53+10,0001,238,471+1%+$105,3000+4+3
D
2017-03-20
EXELPapadopoulos SteliosDirS - Sale+OE$21.66-10,0001,238,471-1%-$216,6000+4+3
D
2017-03-15
EXELWillsey LanceDirM - OptEx$10.53+10,000568,273+2%+$105,3000-8-3
D
2017-03-15
EXELWillsey LanceDirS - Sale+OE$22.86-10,000568,273-2%-$228,6000-8-3
D
2017-03-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$6.20+50,007172,027+41%+$310,1790-8-3
D
2017-03-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$22.53-50,007172,027-23%-$1,126,6580-8-3
2017-03-13
EXELCohen CharlesDirS - Sale$21.82-10,000238,180-4%-$218,200+5+1-4
D
2017-03-10
EXELMarchesi Vincent TDirM - OptEx$3.13+40,000120,070+50%+$125,200+1+1-5
D
2017-03-10
EXELMarchesi Vincent TDirS - Sale+OE$21.98-40,000120,070-25%-$879,200+1+1-5
D
2017-03-03
EXELHessekiel JeffreyEVP, GCM - OptEx$7.27+100,000246,617+68%+$727,000-2-2-4
D
2017-03-03
EXELHessekiel JeffreyEVP, GCS - Sale+OE$23.04-100,000246,617-29%-$2,303,678-2-2-4
DM
2017-03-03
EXELMorrissey MichaelPres, CEOM - OptEx$9.91+200,000249,523+404%+$1,982,000-2-2-4
DM
2017-03-03
EXELMorrissey MichaelPres, CEOS - Sale+OE$22.72-200,000249,523-44%-$4,544,000-2-2-4
2017-03-03
EXELHaley Patrick J.SVP, CommercialS - Sale$23.04-2,500140,400-2%-$57,600-2-2-4
2017-03-03
EXELSenner Christopher J.EVP, CFOS - Sale$22.80-11,000102,181-10%-$250,800-2-5-6
D
2017-03-01
EXELLamb PeterEVP, Scientific Strategy, CSOM - OptEx$7.36+45,00089,728+101%+$331,350-2-5-6
D
2017-03-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$22.19-45,00089,728-33%-$998,550-2-5-6
DM
2017-03-01
EXELPoste GeorgeDirM - OptEx$5.20+76,25077,555>999%+$396,850-2-5-6
DM
2017-03-01
EXELPoste GeorgeDirS - Sale+OE$22.53-76,25077,555-50%-$1,718,185-2-5-6
D
2017-02-01
EXELLamb PeterEVP, Scientific Strategy, CSOM - OptEx$6.92+70,00089,680+356%+$484,300-1+12+13
D
2017-02-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$18.65-70,00089,680-44%-$1,305,500-1+12+13
D
2017-01-03
EXELLamb PeterEVP, Scientific Strategy, CSOM - OptEx$5.74+70,00089,624+357%+$401,800+2+21+34
D
2017-01-03
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$14.65-70,00089,624-44%-$1,025,636+2+21+34
D
2016-12-16
EXELFeldbaum Carl BDirM - OptEx$10.41+25,00048,721+105%+$260,250-3-11+7
D
2016-12-16
EXELFeldbaum Carl BDirS - Sale+OE$17.03-25,00048,721-34%-$425,750-3-11+7
D
2016-12-09
EXELGarber Alan MDirM - OptEx$10.53+10,00061,329+19%+$105,300-2-1+12
D
2016-12-09
EXELGarber Alan MDirS - Sale+OE$16.90-7,83261,329-11%-$132,361-2-1+12
DM
2016-12-05
EXELScangos George ADirM - OptEx$8.99+358,3321,487,243+32%+$3,221,405+2-2-7
DM
2016-12-05
EXELScangos George ADirS - Sale+OE$17.81-204,8941,487,243-12%-$3,649,178+2-2-7
D
2016-12-01
EXELLamb PeterEVP, Scientific Strategy, CSOM - OptEx$5.27+70,00089,624+357%+$368,800+3-3-16
D
2016-12-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$16.66-70,00089,624-44%-$1,166,200+3-3-16
D
2016-12-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$8.99+22,000171,859+15%+$197,780+3-3-16
D
2016-12-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$16.73-22,000171,859-11%-$368,060+3-3-16
AD
2016-09-22
EXELSenner Christopher J.EVP, CFOA - Grant$0.00+20,000127,636+19%+$0+3+3-10
AD
2016-07-15
EXELSenner Christopher J.EVP, CFOF - Tax$8.44-46,751127,636-27%-$394,578+3+3-10
D
2016-11-09
EXELMorrissey MichaelPres, CEOM - OptEx$8.99+200,000251,329+390%+$1,798,000-1+1-4
D
2016-11-09
EXELMorrissey MichaelPres, CEOS - Sale+OE$15.00-200,000251,329-44%-$3,000,000-1+1-4
D
2016-11-09
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$8.99+22,000171,859+15%+$197,780-1+1-4
D
2016-11-09
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$15.00-22,000171,859-11%-$330,000-1+1-4
D
2016-11-09
EXELLamb PeterEVP, Scientific Strategy, CSOM - OptEx$5.17+70,00089,624+357%+$362,000-1+1-4
D
2016-11-09
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$13.15-70,00089,624-44%-$920,500-1+1-4
D
2016-09-22
EXELHessekiel JeffreyEVP, GCA - Grant$0.00+16,250246,617+7%+$0+1-17-27+41
D
2016-09-22
EXELLamb PeterEVP, Scientific Strategy, CSOA - Grant$0.00+16,25089,624+22%+$0+1-17-27+41
D
2016-09-22
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOA - Grant$0.00+20,000170,247+13%+$0+1-17-27+41
D
2016-09-22
EXELSenner Christopher J.EVP, CFOA - Grant$0.00+20,000154,387+15%+$0+1-17-27+41
D
2016-09-26
EXELMorrissey MichaelPres, CEOA - Grant$0.00+60,000251,329+31%+$0+1-17-27+41
D
2016-09-22
EXELSmith JulieDirA - Grant$0.00+763763New+$0+1-17-27+41
D
2016-08-31
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOM - OptEx$9.73+132,662150,247+754%+$1,290,801+5+4+10+99
D
2016-08-31
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$10.98-131,155150,247-47%-$1,440,082+5+4+10+99

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top